Where is the opportunity in the therapeutic antibody market?
Drug Discovery World
APRIL 8, 2024
Dr O’Donnell-Tormey will address the opportunities, innovations and challenges in the therapeutic antibody space. Dr Levy will outline the significance of belimumab, a monoclonal antibody that inhibits B-cell activating factor. What you will learn: Where is the opportunity in the mAb market and where is the market heading?
Let's personalize your content